SWOG clinical trial number
SWOG-9212

Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma
Activated
05/15/1994
Closed
01/15/1997

Research committees

Gynecologic Cancer

Publication Information Expand/Collapse

1999

Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: A Southwest Oncology Group study

EA Poplin;PY Liu;JE Delmore;S Wilczynski;DF Moore Jr;RK Potkul;GR Weiss;EV Hannigan;DS Alberts Gynecologic Oncology 74:432-435

1998

Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma (SWOG 9212).

EA Poplin;PY Liu;J Delmore;S Wilczynski;D Alberts Proc of the American Society of Clinical Oncology 17:373a(#1436)